TerminatedInterventionalNot ApplicableUpdated Jun 13, 2022
Cytosponge Protocol IRB 11-006429
Cytosponge Protocol
ClinicalTrials.gov ID
NCT01585103
Lead Sponsor
Mayo ClinicOTHER
Overall Status
Terminated
Study Type
Interventional
Phase
Not Applicable
Enrollment
86Actual
Last Update Posted
Jun 13, 2022Actual
Start Date
Dec 2012
Primary Completion Date
Jun 7, 2016Actual
Completion Date
Jun 7, 2016Actual
Official Title
Cytosponge Protocol
Brief Summary
This study is being done to collect data on the potential use of the cytosponge as non-invasive tool in evaluating patients with eosinophilic esophagitis.
Eosinophilic Esophagitis
Cytosponge
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients between the ages of 18 and 65 with eosinophilic esophagitis including lactating or pregnant women undergoing clinically indicated endoscopy and esophageal biopsy.
Exclusion Criteria:
Patients for whom clinically indicated endoscopy is not safe. Patients who have small caliber esophagus, an esophageal stricture that will not permit passage of the gelatin capsule or are unable to swallow the capsule.
Vulnerable populations, such as those with diminished mental acuity, will be excluded.
Patients with known Lidocaine/Acetylcysteine allergies